MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

csiro: polynovo cost benefit analysis, page-12

  1. 18,160 Posts.
    lightbulb Created with Sketch. 1671
    exactly..and the name is changing too
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.